MLPT MapLight Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $175M and sold $30.2M on the open market.
Recent MLPT insider trades
- Oct 15, 2026: Kroeger Christopher A. sold 73,691 shares ($595K)
- Oct 15, 2026: Gillis Jonathan sold 10,167 shares ($82.1K)
- Oct 15, 2026: Lillie James Woodruff sold 11,513 shares ($93.0K)
- Oct 15, 2026: Hanson Kristopher sold 9,020 shares ($72.9K)
5%+ owners
- Catalyst4, Inc.: 49.9% (Schedule 13D/A, filed Aug 18, 2026)
- T. Rowe Price Investment Management, Inc.: 7.4% (Schedule 13G/A, filed May 15, 2026)
- Forbion Growth Opportunities Fund III Cooperatief U.A.: 7.1% (Schedule 13G, filed Feb 17, 2026)
- Nan Fung Group Holdings Limited: 5.5% (Schedule 13G, filed Aug 20, 2026)